Abstract Several cell types contribute to atherosclerotic calcification. Myeloid calcifying cells (MCCs) are monocytes expressing osteocalcin (OC) and bone alkaline phosphatase (BAP). Herein, we tested whether MCCs promote atherosclerotic calcification in vivo. We show that the murine spleen contains
? BAP ? cell-conditioned medium (CM) promoted calcification by cultured vascular smooth muscle cells (VSMC) more than CM from OC -BAP -cells. A genomic and proteomic investigation of MCCs identified allograft inflammatory factor (AIF)-1 as a potential candidate of this paracrine activity. AIF-1 stimulated VSMC calcification in vitro and monocyte-specific (CD11b-driven) AIF-1 overexpression in ApoE -/-mice increased calcium content in atherosclerotic areas. In conclusion, we show that murine OC
Introduction
Atherosclerosis is a complex inflammatory disease of the artery wall [10] . Ectopic calcification is a common feature of advanced atherosclerotic plaques and it affects vascular function [2] . While extensively calcified lesions may be more stable than lipid-rich lesions, spotty neointimal calcifications are believed to increase lesion vulnerability and probability of rupture [23, 26] . The mechanisms that drive vascular calcification are manifold and there are several cell types potentially involved. Medial calcification appears to arise mainly from osteogenic transdifferentiation of resident smooth muscle cells [23, 26] or mesenchymal cells, such as adventitial cells and pericytes [12, 20] . On the other hand, circulating calcifying cells may contribute to intimal calcification within atherosclerotic lesions or heart valves, by recruitment from the bone marrow and bloodstream [7, 9, 20] . According to recent data [12] , a new paradigm indicates that circulating calcifying cells may have pathophysiological, clinical and therapeutic implications in vascular and bone disorders. We have recently identified a subpopulation of circulating monocyte/macrophage lineage cells which show calcifying ability using in vitro assays and in vivo models of ectopic calcification, such as the subcutaneous Matrigel plug. Such cells express osteocalcin (OC) and bone alkaline phosphatase (BAP), retain myeloid features and are increased in the circulation and bone marrow of diabetic patients [11] . These myeloid calcifying cells (MCCs) can also be obtained after culture of peripheral blood mononuclear cells (PBMCs) and undergo calcification in vitro and when implanted into subcutaneous Matrigel plugs [11] . Although OC ? BAP ? cells were more frequent in extensively calcified atherosclerotic lesions of diabetic patients compared to less calcified lesions of non-diabetic patients, whether MCCs from the bloodstream truly contribute to vascular calcification was unclear. Therefore, the present study was designed to test the hypothesis that OC ? BAP ? cells promote calcification of atherosclerotic lesions in mice.
Materials and methods

Animals
C57Bl/6 mice constitutively expressing GFP (strain C57BL/6-Tg(CAG-EGFP)1Osb/J from Charles River Laboratories) were used as donors of bone marrow cells to be injected into 8-or 40-week-old ApoE -/-mice (strain C57Bl/6.129P2-Apoe tm1Unc J from Charles River Laboratories). Wild type C57Bl/6 mice were from the in-house colony. Eight-week-old ApoE -/-mice were fed a standard chow diet, housed in controlled humidity and temperature conditions, with free access to food and water for 24 weeks after cell injection to allow development of atherosclerosis. Forty-week-old ApoE -/-mice, also fed a standard chow diet, had already developed advanced atherosclerosis and were maintained for 2 weeks after cell injection. Generation of C57Bl/6 ApoE -/-AIF-1 tg mice has been described previously [18, 19] . Paraffin-embedded samples from 15-week-old ApoE -/-AIF-1 tg and ApoE -/-AIF-1 wt mice on a standard chow diet were obtained and analyzed. The protocol was approved by the Animal Ethical Committee of the University of Padova and experiments were conducted according to the NIH principles of laboratory animal care (publication no. 85-23, revised 1985).
Culture of murine calcifying cells
Murine calcifying cells were isolated from the mouse spleen as a large source of mononuclear cells, using a protocol similar to that optimized to yield human MCCs [11] . The spleen was surgically removed from wild type C57Bl/6 mice before killing, minced and filtrated to obtain a single cell suspension. Red blood cells were lysed and mononuclear cells separated using Histopaque 1077 (Sigma-Aldrich). Cells (3 9 10 6 /cm 2 ) were plated in 24-well plates coated with Matrigel (Becton-Dickinson) for 3 weeks in complete osteogenic medium (MesenCult TM medium ? osteogenic stimuli, Stem Cells Technologies Inc.). The medium was changed first after 1 week and then every 3 days. Two weeks after plating, beta-glycerophosphate (final concentration 3.5 mM) was added to the culture for 1 week to stimulate calcium deposition. At the end of the 3-week-culture protocol, wells were stained with Von Kossa and Alizarin red.
Flow cytometry and cell sorting
Spleen-derived mononuclear cells from GFP ? animals were stained with PE-conjugated anti-OC (R&D System) and APC-conjugated anti-BAP (R&D Systems, clone B4-78) monoclonal antibodies for cell sorting (BD FACSAria Ten days later, before killing, mice were subjected to a microcomputed tomography scan on a microCT eXplore Locus system (GE Healthcare).
Transendothelial migration
To test the ability of OC ? BAP ? cells to undergo transendothelial migration, we used a modified transwell migration assay, as previously described [16] . Briefly, freshly isolated, unlabeled PBMCs from healthy young blood donors were left to adhere to or transmigrate through a monolayer of green fluorescence-labeled (PKH67, SigmaAldrich) human aortic endothelial cells (HAECs; Lonza) grown to confluence on the filter membrane of sterile 3-micron pore, 12-well format transwell migration inserts (BD Falcon). After 6 h, transmigrating PBMCs were harvested from the lower compartment, while non-adherent (floating) and adherent cells were harvested from the upper compartment by sequential washing/detachment. The three cell fractions (floating, adherent and migrated) were individually stained with OC and BAP as described above 
Microarray
Total RNA was isolated using TRIzol (Invitrogen) followed by cleanup with the RNeasy Mini Kit (Qiagen). RNA integrity was evaluated with the Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA) and quantified with a NanoVue spectrophotometer (GE Healthcare Life Sciences, Baie d'Urfe, QC). For gene expression profiling, 250 ng of RNA was hybridized to Human Genome U133 Plus 2.0 Arrays (Affymetrix). Expression values were generated from fluorescence signals using the robust multi-array average procedure. Specifically, intensity levels have been background adjusted, normalized using quantile normalization, and log2 expression values calculated using median polish summarization and Entrez custom chip definition files for human arrays (version 15.1.0). The gene expression data are published online at GEO series GSE47060.
Real-time quantitative PCR
Total RNA was extracted using RNeasy kit (Qiagen), then reverse transcribed to generate cDNA using the first-strand cDNA synthesis kit from Invitrogen. Gene-specific primer pairs were designed using primer-BLAST (NCBI) and were validated prior to use by gradient PCR and gel analysis to test for optimal annealing temperature, reaction efficiency and specificity. Real-time PCR with Fast SYBR Green detection was performed using an 7900HT fast realtime qPCR System (Applied Biosystems) and the following primers: mouse Ubiquitin C (reference gene) FW 5
Expression data were normalized to the mean of housekeeping gene ubiquitin C to control the variability in expression levels and were analyzed using the 2 (-DDCT) method.
Proteomic analysis
Circulating cells were lysed by sonication on ice in a hypotonic buffer (50 mM HEPES pH 7.5, 1 % Triton, protease inhibitor cocktail). Proteins (120 lg) from each sample were precipitated overnight at -20°C with cold acetone. Protein pellets were dissolved in 120 lL of 0.5 M TEAB, reduced, alkylated and trypsin digested according to the iTRAQ manufacturer's instructions. Samples were split in two aliquots of 60 lg to perform two technical replicates with tag swapping. Following iTRAQ labeling, samples were pooled and vacuum concentrated. The dried iTRAQ labeled sample was dissolved in 400 lL of equilibration buffer (5 mM KH 2 PO 4 , 25 % acetonitrile, pH 2.9), and fractionated with a strong cation exchange cartridge (AB Sciex, Canada) in a step-wise mode, using the following concentrations of KCl: 50, 100, 150, 200, 350 mM. Each SCX fraction was then dried under vacuum, resuspended in 500 lL of 0.1 % formic acid, desalted using C18 cartridges (Sep-Pack, C18, Waters). Samples from each SCX fraction were dried under vacuum and then dissolved in 50 lL of 0.1 % formic acid, obtaining a final concentration of 1 lg/lL. The MS analyses were performed on a LTQ-Orbitrap XL mass spectrometer (Thermo Fisher Scientific) coupled with a nano-HPLC Ultimate 3000 (Dionex, Thermo Fisher Scientific). The same samples fractionated with a Tempo TM LC MALDI Spotting System (AB Sciex) were also analyzed with a MALDI-TOF/TOF 4800 mass spectrometer (AB Sciex). Collected data were analyzed using Proteome Discoverer 1.2 (Thermo Fisher Scientific) connected to a Mascot Search Engine (version 2.2.4, Matrix Science, UK). MS/MS data obtained from each SCX fraction and with the different instrumental platforms were treated as technical replicate for quantification purposes. Data were filtered considering as positive hits the proteins identified with at least two unique peptides with medium confidence (FDR 5 %) and quantified with at least two independent peptides. OC
? BAP ? over OC -BAP -cell ratio C1.6 was set as threshold for protein overexpression. -/-and control mice, paraffin was removed by melting blocks at 60°C. Tissues samples were put in xylene 100 % for 10 min at room temperature and then hydrated through a descending alcohol series to water. Samples were put in 100 ll of 0.6 N HCl, heated at 99°C for 5 min and lysed through two cycles of freezing and thawing by snap freezing in liquid nitrogen and thawing on ice. Samples were left overnight in 0.6 N HCl before mechanical disruption with TissueLyser (Qiagen). HCl was neutralized with 100 lL of 0.1 N NaOH, 0.1 % SDS. Samples were centrifuged at room temperature at 13,0009g. Supernatant were assessed for calcium concentration using O-cresolphthalein complexone method (Chema Diagnostica, Italy). Protein concentration was assessed using NanoVue Plus (Ge Life Sciences).
Histology and confocal microscopy
To track the fate of injected GFP ? cells, we tried different strategies of confocal microscopy (Leica TCS SP5). The endogenous GFP signal was weak and barely above background green signal, as determined by necrotic debris, oxidized lipids and calcium deposits within atherosclerotic lesions. When stained with an anti-GFP antibody (Rabbit Anti-GFP, Life Technologies, UK) and green secondary antibody (Donkey Anti-Rabbit DyLight 488, Jackson ImmunoResearch, UK), signal amplification was insufficient to discriminate positive areas from the background. We therefore used a blue-labeled secondary antibody (Donkey Anti-Rabbit AMCA, Jackson) to amplify the GFP signal and nuclei were counterstained in red with propidium iodine (PI). With this combination, only cells with simultaneous blue and green cytoplasm and a defined red nuclear shadow were considered as homed GFP
? cells.
Statistical analysis
Data are expressed as mean ± standard error. Comparison between two or more groups was performed using ANOVA and Student's t test, respectively. Bonferroni correction was applied to account for multiple testing and statistical significance was accepted at p \ 0.05.
Results
Isolation of murine calcifying cells
We have previously shown that culture of human PBMC in osteogenic conditions yields a population of OC-and BAPexpressing cells that calcify in vitro and in vivo. Herein, we have used a similar protocol to isolate murine calcifying cells in vitro: spleen-derived mononuclear cells were able to mineralize 3 weeks after plating, as shown by Von Kossa and Alizarin red staining (Fig. 1) 
BAP
-and noninjected; n = 5/group) spontaneously green fluorescent cells (nuclei surrounded by green fluorescence, Fig. 6a ) were detectable in sections of atherosclerotic lesions, but non-specific signal was also abundant and the hypothetical GFP signal was barely above the background, especially near areas of oxidized lipid accumulation and calcification. Amplification of the GFP signal with an indirect green fluorescent immunodetection slightly improved resolution, but did not allow a clear discrimination from background, especially in advanced and complex lesions. Therefore, we used a blueconjugated indirect anti-GFP staining and counterstained nuclei in red because autofluorescence of atherosclerotic lesions was lower in the blue than in the green channel. This allowed us to better identify injected cells as a red nucleus surrounded by a blue cytoplasm (anti-GFP) co-localized with endogenous green fluorescence (Fig. 6b-d ).
With this specific method, we detected a very small number of injected cells within atherosclerotic lesions (on average less than 1 cell per section), with no difference in atherosclerotic areas of mice injected with OC ? BAP ? compared to mice injected with OC -BAP -cells. As this highly specific method may lead to an underestimation of the amount of GFP ? cells in the lesions, we performed a qPCR analysis of the GFP mRNA in vascular specimen extracts obtained from OC ? BAP ? and OC -BAP -cell-injected mice of both EXP-1 and EXP-2. We found that the GFP transcript was undetectable (or below detection limit) at both timepoints, as it was undistinguishable from the negative control represented by a non-GFP tissue (Fig. 6e) . Sequencing of the late amplification products revealed only no GFP signal (not shown). These data indicate that the local contribution of injected MCCs to atherosclerotic calcification is very small 
-cell-injected mice were stained using the pentachrome protocol in which the black coloring is for nuclei and elastic fibers, yellow for collagen fibers, blue for mucin and bright red for fibrin and red for muscle. 1; Fig. 7a) . A pathway analysis run on the DAVID platform [15] identified calcium handling as the second most enriched functional annotation cluster. Among calcium-binding proteins, allograft inflammatory factor-1 (AIF-1) was strongly upregulated as gene (4.6-fold) and protein (3.1-fold). We validated AIF-1 mRNA upregulation in freshly sorted human and mouse OC ? BAP ? versus OC -BAP -cells, as well as AIF-1 protein expression by flow cytometry on human cells (Fig. 7b) . Based on the paracrine hypothesis, vascular smooth muscle cells (VSMC) were challenged with conditioned media from freshly isolated human OC Insets show a red nucleus surrounded by blue and green GFP ? cytoplasm (arrow). In the close vicinity, an elongated vertical calcification, hyperfluorescent in all channels and devoid of a nuclear shadow (asterisk) can be interpreted as a calcification. d A nucleated cells with cytoplasmic GFP signal in the green and blue channel close to a non-GFP cell and a non-nucleated green and blue signal. Scale bar 50 lm. e qPCR analysis of the GFP transcript in RNA samples extracted from atherosclerotic specimen of OC ? BAP ? or OC -BAP -cell-injected mice (samples of interest). The positive and controls were muscle samples from a constitutively expressing GFP mouse and a wild type (GFP-neg) mouse, respectively. The amplification plots show that there was no difference between the samples of interest and the negative control. Sequencing of the amplification products from the samples of interest revealed no GFP sequence cells or control OC -BAP -cells. We found that VSMC exposed to OC ? BAP ? cell-conditioned medium showed a 2.5-fold higher calcification compared to the control medium and a significant 40 % increased calcification compared to VSMC exposed to OC -BAP -cell-conditioned medium. In addition, VSMC incubated with 5 nM AIF-1 showed increased calcification compared with the control condition (Fig. 7c) .
To confirm that excess AIF-1 expression drives vascular calcification by MCCs in vivo, we analyzed samples from ApoE -/-AIF-1 tg mice, in which overexpression of AIF-1 is driven by the CD11b promoter and is thus specific for the monocyte-macrophage lineage, to which MCCs belong. It has been shown previously that these mice have accelerated atherosclerosis [18] . After calcium extraction from tissue samples including the aortic sinus, aortic valve and aortic arch, we found that, compared to control ApoE -/-mice, ApoE -/-AIF-1 tg mice have a marked increase in calcium content (Fig. 7d) . [11] . We used the spleen as a source of cells to be injected into ApoE -/-mice because it has been recently shown that the spleen functions as a buffer of monocytic cells that accelerate atherosclerosis [8] , and is a candidate reservoir of MCCs. In addition, OC ? BAP ? cells from the bone marrow would be contaminated by mesenchymal stem cells expressing OC and BAP [21] , which are rarer in the spleen.
Discussion
The most striking result of the present study is that injection of OC ? BAP ? cells into ApoE -/-mice strongly increased atherosclerotic calcification of early lesions over 24 weeks and of advanced lesions over 2 weeks. This is the sought proof-of-concept demonstration that MCCs are involved in atherosclerotic calcification in vivo and supports the role of circulating cells in this phenomenon [12] . To track the fate of injected cells, we used a genetic approach in which cells are spontaneously fluorescent owing to genomic expression of GFP. Detection of GFP signal in atherosclerotic areas is complicated by the extensive autofluorescence of necrotic debris, oxidized lipids and calcium deposits. It has been demonstrated that a multiparametric and stringent confocal microscopy analysis is needed to reliably detect the presence of injected cells in cardiovascular tissues [4, 5] . Thus, the simple enumeration of green fluorescent cells in the sections of complex tissues likely leads to an overestimation of the homing phenomenon. To overcome this bias, we used specific and stringent criteria to detect injected cells and found that, despite the strong effect on calcification, the number of injected cells present in the lesions at time of sacrifice was very low. Consistently, qPCR performed on RNA isolated from atherosclerotic lesions of mice injected with GFP -BAP -controls. Much interestingly, the calcium handling functional annotation pathway, which is involved in calcification, was enriched in this cluster of genes/proteins. Indeed, 12/57 genes/proteins (21 %) have calcium-binding activity and AIF-1 was among the most upregulated ones. AIF-1 has been previously shown to induce atherosclerosis, restenosis and vascular inflammation by stimulation of VSMC and monocyte-macrophage activity [3, 18, 24, 29] . SM-restricted AIF-1 overexpressing mice on a high fat diet develop accelerated atherosclerosis [24] . By converse, in vivo AIF-1 silencing decreased neointimal hyperplasia in wire-injured rat carotid arteries [25] . AIF-1 is induced by interferon-c, which affects the VSMC phenotype [6] . Therefore, we focused on AIF-1 as a candidate mediator of the pro-calcific potential of MCCs. AIF-1 was able to induce calcification of cultured VSMC, supporting the paracrine hypothesis. Moreover, transgenic ApoE -/-mice with CD11b-driven AIF-1 overexpression showed exacerbated aortic calcification, strongly indicating that AIF-1 activity in monocyte-macrophages stimulates vascular calcification and further supporting the role of AIF-1 in MCCs. Despite that atherosclerosis in these 15-week-old AIF-1 tg mice fed a chow diet was mainly located at the aortic sinus, detailed information about the exact site of excess calcification (plaques, valves, whole aorta, media or adventitia) is presently missing and is a matter of future research. AIF-1 is an actin-binding protein that is also secreted in the extracellular fluids and its serum concentrations are correlated with cardiovascular risk factors [14] . This notion supports the potential role of AIF-1 as a MCC-derived systemic paracrine factor.
In addition to AIF-1, several other calcium-binding proteins were found to be upregulated in MCCs, including S100-A8/9, that have been previously implicated in atherosclerosis [1] . Therefore, mechanisms other than AIF-1 likely contribute to the pro-calcific effect of MCCs, explaining why AIF-1 supplementation induced a smaller increase in VSMC calcification compared to MCC-conditioned medium.
The paracrine hypothesis reconciles the low number of GFP ? cells in the lesions with the extensive calcifications and also provides an explanation for the inconsistent literature about the role of circulating cells in vascular calcification [12] . Using genetic lineage tracking models, Naik et al. [20] recently reported that most (80-98 %) calcifying cells in atherosclerotic lesions of ApoE -/-and LDLr -/-mice are derived form local smooth muscle cells and that circulating cells provide a much smaller contribution. Herein, we suggest that the paracrine activity of circulating myeloid cells is critical for stimulation of calcification by resident cells. This scenario is not surprising, as myeloid cells play major roles in the development and progression of atherosclerosis, mainly by secretory activity and release of cellular components upon cell death [13, 17, 28, 30] . In addition, this figure is similar to that shown for BM-derived smooth muscle cells, which are rarely found in atherosclerotic plaques, but significantly promote development of the lesion [31] . In this framework, our data indicate that OC ? BAP ? cells are the pro-calcific subpopulation of monocytes, and suggest these MCCs and AIF-1 represent therapeutic targets to counter vascular calcification.
